l 158809 has been researched along with Experimental Radiation Injuries in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, WR; Diz, DI; Hsu, FC; Olson, J; Payne, V; Robbins, ME; Tommasi, E; Wheeler, KT; Zhao, W | 1 |
| Conner, KR; Forbes, ME; Payne, VS; Riddle, DR; Robbins, ME | 1 |
| Cohen, EP; Fish, BL; Moulder, JE | 3 |
| Hyjek, E; Jaggi, JS; McDevitt, MR; Scheinberg, DA; Seshan, SV; Sgouros, G | 1 |
| Cohen, EP; Fish, BL; Li, XA; Moulder, JE; Sharma, M | 1 |
| Cohen, EP; Datta, PK; Fish, BL; Lianos, EA; Moulder, JE | 1 |
8 other study(ies) available for l 158809 and Experimental Radiation Injuries
| Article | Year |
|---|---|
The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cognition Disorders; Cranial Irradiation; Dose Fractionation, Radiation; Drug Evaluation, Preclinical; Imidazoles; Male; Radiation Injuries, Experimental; Rats; Rats, Inbred F344; Tetrazoles | 2009 |
Effects of the AT1 receptor antagonist L-158,809 on microglia and neurogenesis after fractionated whole-brain irradiation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Behavior, Animal; Brain; Cell Proliferation; Cognition Disorders; Dentate Gyrus; Humans; Imidazoles; Inflammation; Male; Microglia; Neurogenesis; Neurons; Radiation Dosage; Radiation Injuries, Experimental; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Time Factors | 2010 |
Impact of angiotensin II type 2 receptor blockade on experimental radiation nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Drug Interactions; Imidazoles; Kidney Diseases; Kidney Function Tests; Male; Pyridines; Radiation Injuries, Experimental; Radiation Protection; Radiation Tolerance; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Treatment Outcome | 2004 |
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
Topics: Actinium; Alpha Particles; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Female; Imidazoles; Kidney; Kidney Tubules; Mice; Mice, Inbred BALB C; Mineralocorticoid Receptor Antagonists; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Spironolactone; Tetrazoles | 2006 |
Role of the angiotensin II type-2 receptor in radiation nephropathy.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cell Line; Humans; Imidazoles; Kidney Diseases; Male; Mice; Pyridines; Radiation Injuries, Experimental; Rats; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors | 2007 |
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Imidazoles; Kidney; Kidney Diseases; Kidney Function Tests; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Survival Rate; Tetrazoles; Time Factors; Treatment Outcome | 1998 |
Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bone Marrow Transplantation; Captopril; Imidazoles; Kidney; Lung; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Renal Insufficiency; Renin-Angiotensin System; Tetrazoles | 1998 |
TGF-beta 1 production in radiation nephropathy: role of angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Female; Imidazoles; Kidney Diseases; Kidney Glomerulus; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Tetrazoles; Transforming Growth Factor beta | 1999 |